Clinical Trial Update: Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Sebivo (telbivudine) for chronic hepatitis B has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Sebivo (telbivudine)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Chronic Hepatitis B | Phase 2, Phase 3 | Status: WITHDRAWN